A new cardiac monitoring device from Preventice (Minneapolis, MN) has been cleared by the FDA to help physicians keep an eye on arrhythmia patients as they go about their day.
The BodyGuardian attaches to the patient chest and continuously records ECG, heart rate, heart rate variability, respiration rate, and the person’s activity level. Algorithms licensed from the Mayo Clinic help detect arrhythmia signatures, and physicians can review the data set from the last 30 days to get a broader picture of what’s happening.
The company hopes to make the system commercially available in the U.S. by the end of the year.
Here are Mayo Clinic cardiologists discussing the benefits of remote monitoring of patients:
Product page: BodyGuardian Remote Monitoring System…